Cargando…
Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients
This study investigated the safety and efficacy of mirogabalin, a novel, potent, selective ligand of the α(2)δ subunit of voltage-dependent Ca(2+) channels, for the treatment of postherpetic neuralgia (PHN). In this multicenter, double-blind, placebo-controlled phase 3 study, Asian patients ≥20 year...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485311/ https://www.ncbi.nlm.nih.gov/pubmed/30913164 http://dx.doi.org/10.1097/j.pain.0000000000001501 |